Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

CD31 (JC70) expression in plasma cells: an immunohistochemical analysis of reactive and neoplastic plasma cells.

Govender D, Harilal P, Dada M, Chetty R.

J Clin Pathol. 1997 Jun;50(6):490-3.

PMID:
9378815
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.

Kremer M, Ott G, Nathrath M, Specht K, Stecker K, Alexiou C, Quintanilla-Martinez L, Fend F.

J Pathol. 2005 Jan;205(1):92-101.

PMID:
15586381
[PubMed - indexed for MEDLINE]
4.

Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma.

Hedvat CV, Comenzo RL, Teruya-Feldstein J, Olshen AB, Ely SA, Osman K, Zhang Y, Kalakonda N, Nimer SD.

Br J Haematol. 2003 Sep;122(5):728-44. Erratum in: Br J Haematol. 2003 Nov;123(3):563.

PMID:
12930383
[PubMed - indexed for MEDLINE]
5.

Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome study.

Schwartz TH, Rhiew R, Isaacson SR, Orazi A, Bruce JN.

Neurosurgery. 2001 Nov;49(5):1039-44; discussion 1044-5.

PMID:
11846895
[PubMed - indexed for MEDLINE]
6.

Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.

Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R.

Haematologica. 2000 Aug;85(8):800-5.

PMID:
10942925
[PubMed - indexed for MEDLINE]
Free Article
7.

Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma.

Kanavaros P, Stefanaki K, Vlachonikolis J, Papalazarou D, Rontogianni D, Arvanitis D, Antonakopoulos G, Gorgoulis V, Bai M, Agnantis NJ.

Anticancer Res. 2000 Nov-Dec;20(6B):4619-25.

PMID:
11205312
[PubMed - indexed for MEDLINE]
8.

CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.

Chilosi M, Adami F, Lestani M, Montagna L, Cimarosto L, Semenzato G, Pizzolo G, Menestrina F.

Mod Pathol. 1999 Dec;12(12):1101-6.

PMID:
10619261
[PubMed - indexed for MEDLINE]
9.

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.

Bayer-Garner IB, Sanderson RD, Dhodapkar MV, Owens RB, Wilson CS.

Mod Pathol. 2001 Oct;14(10):1052-8.

PMID:
11598177
[PubMed - indexed for MEDLINE]
Free Article
10.

The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells.

Rawstron AC, Fenton JA, Ashcroft J, English A, Jones RA, Richards SJ, Pratt G, Owen R, Davies FE, Child JA, Jack AS, Morgan G.

Blood. 2000 Dec 1;96(12):3880-6.

PMID:
11090073
[PubMed - indexed for MEDLINE]
Free Article
11.

The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens.

Costes V, Magen V, Legouffe E, Durand L, Baldet P, Rossi JF, Klein B, Brochier J.

Hum Pathol. 1999 Dec;30(12):1405-11.

PMID:
10667416
[PubMed - indexed for MEDLINE]
12.

Immunoreactive cytokeratins in plasmacytomas.

Wotherspoon AC, Norton AJ, Isaacson PG.

Histopathology. 1989 Feb;14(2):141-50.

PMID:
2468596
[PubMed - indexed for MEDLINE]
13.

Extensive extramedullary disease in myeloma. An uncommon variant with features of poor prognosis and dedifferentiation.

Sanal SM, Yaylaci M, Mangold KA, Pantazis CG.

Cancer. 1996 Apr 1;77(7):1298-302.

PMID:
8608506
[PubMed - indexed for MEDLINE]
14.

Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses.

Ioannou MG, Stathakis E, Lazaris AC, Papathomas T, Tsiambas E, Koukoulis GK.

Pathol Oncol Res. 2009 Mar;15(1):25-9. doi: 10.1007/s12253-008-9069-1. Epub 2008 Jun 14.

PMID:
18553158
[PubMed - indexed for MEDLINE]
15.

Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45RO (UCHL-1).

Menke DM, Horny HP, Griesser H, Atkinson EJ, Kaiserling E, Kyle RA.

J Clin Pathol. 1998 Jun;51(6):432-7.

PMID:
9771441
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Cyclin D1 overexpression in multiple myeloma. A morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens.

Athanasiou E, Kaloutsi V, Kotoula V, Hytiroglou P, Kostopoulos I, Zervas C, Kalogiannidis P, Fassas A, Christakis JI, Papadimitriou CS.

Am J Clin Pathol. 2001 Oct;116(4):535-42.

PMID:
11601138
[PubMed - indexed for MEDLINE]
Free Article
17.

An evaluation of immunohistologic stains for immunoglobulin light chains in bone marrow biopsies in benign and malignant plasma cell proliferations.

Wolf BC, Brady K, O'Murchadha MT, Neiman RS.

Am J Clin Pathol. 1990 Dec;94(6):742-6.

PMID:
2123076
[PubMed - indexed for MEDLINE]
18.

[Determination proliferative activity of myeloma cells in histologic material].

Fabian P, Kren L, Nenutil R.

Cesk Patol. 2004 Apr;40(2):46-9. Czech.

PMID:
15233016
[PubMed - indexed for MEDLINE]
19.

BCL-X expression in multiple myeloma: possible indicator of chemoresistance.

Tu Y, Renner S, Xu F, Fleishman A, Taylor J, Weisz J, Vescio R, Rettig M, Berenson J, Krajewski S, Reed JC, Lichtenstein A.

Cancer Res. 1998 Jan 15;58(2):256-62.

PMID:
9443402
[PubMed - indexed for MEDLINE]
Free Article
20.

Frequent expression of haemopoietic and non-haemopoietic antigens by reactive plasma cells: an immunohistochemical study using formalin-fixed, paraffin-embedded tissue.

Beschorner R, Horny HP, Petruch UR, Kaiserling E.

Histol Histopathol. 1999 Jul;14(3):805-12.

PMID:
10425550
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk